CRANBURY, N.J.--(BUSINESS WIRE)--Michael J. Hennessy Associates, Inc. (MJH Associates), a full-service healthcare communications company, announces the expansion of its Strategic Alliance Partnership (SAP) program with the addition of the American Lung Association. The partnership will extend across multiple MJH Associates franchises including CURE®, Rare Disease Communication®, MD Magazine® and Contagion®.
In making the announcement, Michael J. Hennessy Jr., president of MJH Associates, said, “We are excited to announce this new partnership with the American Lung Association, an organization that has been on the forefront of finding a cure for lung diseases, providing resources to patients and caregivers, and raising public awareness about lung health. Together, we will advance and educate the lung disease community as we optimize patient outcomes.”
American Lung Association has led the fight for lung health for over 110 years. The mission of the organization is to save lives by improving lung health and preventing lung disease through education, advocacy and research. Since 2014, the American Lung Association has led a successful public awareness initiative, LUNG FORCE, a nationwide movement to unite Americans against lung cancer and for lung health.
“Serving as the nation’s premier resource for lung health, the American Lung Association is pleased to partner with MJH to reach more patients, ensuring those living with a lung disease have science-based information to help them make informed decisions that might improve their quality of life,” said American Lung Association Assistant Vice President of Health Education Katherine Pruitt.
The Strategic Alliance Partnership program builds a community of advocacy groups, medical associations and medical institutions fostering collaboration and an open exchange of information for the ultimate benefit of patients and their families. CURE®, Rare Disease Communication®, MD Magazine® and Contagion® and various trusted organizations. During this collaboration, the American Lung Association will offer quality content, including research updates and management strategies to better educate patients, families and medical professionals about treatment options, emerging research and patient support groups.
About American Lung Association
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease, through research, education and advocacy. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to improve the air we breathe; to reduce the burden of lung disease on individuals and their families; and to eliminate tobacco use and tobacco-related diseases. For more information about the American Lung Association, a holder of the Better Business Bureau Wise Giving Guide Seal, or to support the work it does, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org.
CURE Media Group is the leading resource for cancer updates, research and education. It combines a full suite of media products, including its industry-leading website, CUREtoday.com; innovative video programs, such as CURE Connections®; a series of widely attended live events; and CURE® magazine, which reaches over 1 million readers. CURE Media Group is part of the Cranbury, New Jersey-based Michael J. Hennessy Associates, Inc. family of businesses, which includes the acclaimed OncLive® (www.onclive.com) platform of resources for the practicing oncologist. For more information, visit curetoday.com or www.mjhassoc.com.
About Rare Disease Communications®
Rare Disease Communications® is a healthcare communications and media company focused on the rare disease community and dedicated to raising awareness of rare diseases and orphan drugs so patients will be diagnosed and treated more efficiently. Rare Disease Communications® is part of the Michael J. Hennessy Associates, Inc. (MJH Associates) family of businesses, based in Cranbury, New Jersey. MJH Associates is dedicated to improving quality of life through healthcare education, research and communication. To learn more about MJH Associates, visit www.mjhassoc.com and for Rare Disease Communications, visit: www.raredr.com.
About MD Magazine®
MD Magazine® is a comprehensive clinical news and information portal that provides physicians and other healthcare professionals with up-to-date, specialty- and disease-specific resources designed to help them deliver better care to patients. Readers have access to breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors and other resources. MD Magazine® is part of Michael J. Hennessy Associates, Inc., a full-service healthcare communications company offering education, research, and medical media. For more information, visit www.mdmag.com.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets and Outbreak Monitor, we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes. For more information, visit: http://www.contagionlive.com/
About Michael J. Hennessy Associates
A full-service healthcare communications company offering education, research and medical media, Michael J. Hennessy Associates, Inc., is dedicated to providing healthcare professionals with the information and resources they need to optimize patient outcomes. The Cranbury, New Jersey-based company combines the reach and influence of its powerful portfolio of print and digital product lines, live events, educational programs and custom market research with the customer service focus and customization capabilities of a boutique firm. Clients include world-leading pharmaceutical, medical device, diagnostic and biotech companies. For more information, please visit http://www.mjhassoc.com.